Jim Wassil serves as the Executive Vice President and Chief Operating Officer at VAXCYTE INC, a biotechnology company focused on developing novel vaccines to prevent or treat bacterial infectious diseases. In his role, Wassil is responsible for overseeing the company's operations, ensuring the efficient execution of its strategic objectives, and contributing to the overall growth and success of the organization. His leadership and expertise have been instrumental in guiding VAXCYTE through various stages of development and bringing the company closer to its goal of delivering innovative vaccine solutions to patients worldwide. Prior to joining VAXCYTE, Wassil held several key positions in the biotechnology and pharmaceutical industries, amassing a wealth of experience and knowledge in drug development, operations, and business strategy. He has a proven track record of successfully leading teams, managing complex projects, and driving organizational growth. Wassil's professional background includes roles at prominent companies such as Genentech, where he served as Vice President of Operations, and Onyx Pharmaceuticals, where he held the position of Senior Vice President of Technical Operations. Throughout his career, he has demonstrated a strong commitment to advancing healthcare through the development of life-saving therapies and vaccines. As a key member of VAXCYTE's executive team, Wassil plays a crucial role in shaping the company's future. He works closely with other leaders to develop and implement strategies that support the company's mission and vision. Wassil's dedication to operational excellence, combined with his passion for improving patient outcomes, has made him an invaluable asset to VAXCYTE. Under his guidance, the company continues to make significant progress in its efforts to revolutionize the field of vaccine development and address the unmet needs of patients around the world.